8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 or 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): October 20, 2022

Rennova Health, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

001-35141	68-0370244
(Commission File Number)	(I.R.S. Employer Identification No.)

400 S. Australian Avenue, Suite 800, West Palm Beach, Florida	33401
(Address of Principal Executive Offices)	(Zip Code)

(561) 855-1626

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered under Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
None	None	None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure

On October 20, 2022, Rennova Health, Inc. (the “Company”) issued a press release announcing that Seamus Lagan, our Chief Executive Officer, would be interviewed on Uptick Newswire’s “Stock Day” podcast with Everett Jolly. A copy of the press release is attached hereto as Exhibit 99.1 and a transcript of the interview is attached hereto as Exhibit 99.2.

The information furnished pursuant to this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

Exhibit No.	Exhibit Description
99.1	Press Release dated October 20, 2022
99.2	Transcript of Interview of Seamus Lagan
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 20, 2022	RENNOVA HEALTH, INC.
	By:	/s/ Seamus Lagan
		Seamus Lagan
		Chief Executive Officer
		(principal executive officer)

3

EX-99.1

Exhibit 99.1

RENNOVA HEALTH, INC. PROVIDES Q3 2022 PERFORMANCE UPDATE

WEST PALM BEACH, Fla. (Oct 20, 2022) – Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan recently joined Stock Day host Everett Jolly to provide an update on Q3 2022 performance, and other activities.

Jolly began the interview by referring to the previous quarterly reports and asked if the Company expected a positive report for the third quarter. Lagan responded by confirming a continued improvement in admissions and cash collections and estimated net revenues for the 3^rd quarter were over $4,000,000, making it the best quarter in the past few years.

Jolly asked if there was any further progress from the previous press release on the proposed behavioral health services initiative. Lagan confirmed that new management were finalizing a plan to open the new business in phases, starting with detox and residential care utilizing available space at the Company’s Big South Fork Hospital, using another available building on the same hospital’s campus for outpatient services and then considering long-term options to utilize part of the space at the Company’s closed Jamestown Hospital facility.

Jolly then asked for an update on InnovaQor, Inc. and the plans after the sale of the Company’s software division to InnovaQor. Lagan confirmed that InnovaQor had recently became a fully reporting public company and was in the process of changing its trading symbol (currently VMCS). He further confirmed the intention of InnovaQor to raise capital to execute on its business plan and confirmed that Rennova was considering the options and timing to distribute some of the shares it owned in InnovaQor, to its shareholders.

Jolly ended the interview by asking Lagan what message he would like the Company’s shareholders to take away from the interview. Lagan responded by saying that he believed the most recent quarters demonstrate a continued improvement in the operations and an ongoing reduction in losses from previous years. He said that he believed this trend would continue.

To hear Seamus Lagan’s entire interview, follow the link to the podcast here:

https://audioboom.com/posts/8177068-rennova-health-inc-is-featured-on-a-the-stock-day-podcast

About Rennova Health, Inc.

Rennova Health, Inc. (“Rennova,” the “Company,” “we”, “us”, “its” or “our”) is a provider of health care services. The Company owns one operating hospital in Oneida, Tennessee known as Big South Fork Medical Center, a hospital located in Jamestown, Tennessee that it plans to reopen, a physician’s practice in Jamestown, Tennessee that it plans to reopen and a rural clinic in Kentucky. For more information, please visit www.rennovahealth.com

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

Contact:

Rennova Health

561-855-1626

info@rennovahealth.com

EX-99.2

Exhibit 99.2

Rennova Health Interview

CEO Seamus Lagan on Uptick Newswire October 2022

Speakers: Everett Jolly and Seamus Lagan

Jolly: On today’s show I’m bringing back a returning guest. He was on my show last month in September. I’m talking about no other than Rennova Health, Inc. You can find them on the OTC Markets under the ticker symbol ‘RNVA’. With us today is the CEO, who is going to bring us up to speed, Mr. Seamus Lagan. Seamus, welcome back to the show.

Lagan: Thanks Everett, it’s good to be back on again.

Jolly: The last time that you were on the show in September, we had a lot of highlights. One, last quarter was profitable, hospital operations significantly improved and revenues also improved immensely. That being said, I know the third quarter financial statements won’t be due until November 15th, but can you give us some sort of idea of how you’re running, the run rate and what you see going forward?

Lagan: Thankfully, we have had a continuation of that trend. We have had a continued increase in volume and continued improvement in collections. Subject to review by the auditors before the financial statements go out, it looks like we are going to report $4 million or more of revenue for the third quarter. That is the best quarter we have had in a few years now, it is going in the right direction and we are looking forward to continuing this trend. Obviously, the facility has some limits with what it can do without some capital investment, but all in all it has been a good third quarter, and I believe the financial statements in November will reflect that continued improvement.

Jolly: Let’s talk about the behavioral health division; are we still on schedule with Myrtle?

Lagan: We are. We are finalizing a plan to open separate phases. Obviously, we have property or space in our Big South Fork facility, so the first phase will be to utilize that empty space. It is probably the least capital intensive to get it up and running. We also have a separate building that we own in that same site, and we intend to open an OBOT in that area. Then we will turn our focus to the Jamestown hospital building and we have to look to try and reopen that hospital. We are continuing to consider our options and it certainly looks like we are leaning towards using a portion of that building for behavioral health services, and that will be quite exciting. It will take a little time, but everything is going in the right direction for Myrtle.

Jolly: It’s been a long time since we talked about your investment in InnovaQor, and I know that you have a significant investment in that company from the separation of your software division into that company. How is Rennova going to see the benefit for its shareholders from the investment side?

Lagan: It has been a while since we talked about it. InnovaQor is now a fully-reporting company. I believe the board is taking the final steps to change the VMCS trading symbol to something closer related to the InnovaQor name. So, being fully reporting now gives that company an opportunity to raise a little capital - some capital required to expand the existing products and some capital for the new platform that company is going to launch. We are still very excited about that. For Rennova and its shareholders, we are owed a little money back from that company and we have a significant investment in it, so it will be good if we can get that company to a point where Rennova can sell a little bit of its holding or consider our options for how to distribute some of the shares we own to our Rennova shareholders. We have always said we would do that, and I believe that day is coming closer. I don’t want to estimate a timeframe, Everett, but that is still in the cards and we look forward to being able to do that.

Jolly: The company is starting to turn back to profitability as hospital operations have significantly improved. That being said, what is it you want my listeners to take away from today’s interview?

Lagan: Well hopefully the previous statements that we have made and the belief that we could make this company profitable, hopefully the numbers are starting to demonstrate our commitment to doing that. I remain very committed to getting this fully turned around to where it is profitable enough to carry all of its costs. It is great to have the operations profitable and paying their own way, and the financial statements themselves show a significant reduction in losses. So, I think we continue to make a lot of progress with our debt holders and anybody that is owed money by the company. So, we are looking forward to continuing with the same trend, and I think you’ll see a very different company evolve over the next 6 to 12 months.

Jolly: Seamus, I want to thank you for stopping by and coming on the show. Hopefully you come back in 40 to 50 days to give us an update. Thank you, Sir.

Lagan: I appreciate the opportunity to provide you the update, thank you very much for your time.

XML

Cover	Oct. 20, 2022
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Oct. 20, 2022
Entity File Number	001-35141
Entity Registrant Name	Rennova Health, Inc.
Entity Central Index Key	0000931059
Entity Tax Identification Number	68-0370244
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	400 S. Australian Avenue
Entity Address, Address Line Two	Suite 800
Entity Address, City or Town	West Palm Beach
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33401
City Area Code	(561)
Local Phone Number	855-1626
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false